The test uses a panel of tumor antigens to diagnose autoantibodies produced by the patient’s immune system when lung cancer is present.
Read More
The new, nearly $1.5 million contract with further the development of a panel of assays designed to provide a fast and accurate way to identify and characterize biomarkers estimated to constitute up to 9% of NSCLC cases.
Read More
Mid America Clinical Laboratories is a joint venture clinical laboratory owned by Quest Diagnostics, Community Health Network, St. Vincent Health, and CoLab.
Read More
Four gene variants found in non-small cell lung cancer patients indicate an increased risk of death.
Read More
The test addresses high-volume, high-value need with broad coverage of validated mutations.
Read More